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Summary
Inappropriate transcriptional repression involving histone deacetylases (HDACs) is a prominent cause for the development
of leukemia. We now identify faulty expression of a specific mediator of transcriptional repression in a solid tumor. Loss
of the adenomatosis polyposis coli (APC) tumor suppressor induces HDAC2 expression depending on the Wnt pathway
and c-Myc. Increased HDAC2 expression is found in the majority of human colon cancer explants, as well as in intestinal
mucosa and polyps of APC-deficient mice. HDAC2 is required for, and sufficient on its own to prevent, apoptosis of colonic
cancer cells. Interference with HDAC2 by valproic acid largely diminishes adenoma formation in APCmin mice. These findings
point toward HDAC2 as a particularly relevant potential target in cancer therapy.
Introduction mSin3, N-CoR, and SMRT, which recruit HDACs to transcription
factors (Glass and Rosenfeld, 2000). HDAC inhibitors are con-
Carcinogenesis is a multistep process during which cells acquire sidered as candidate drugs in therapy for leukemia, but appar-
several critical features due to genetic instability and alterations ently also in various other forms of cancer, including those of
in gene expression (Hanahan and Weinberg, 2000). In promyelo- nonhematopoietic origin (Johnstone, 2002; Kra¨mer et al., 2001;
cytic leukemia, a prominent cause is the expression of fusion Marks et al., 2001; Melnick and Licht, 2002; Remiszewski, 2002).
proteins from chromosomal translocations that code for aber- However, compared to the fusion proteins serving aberrant tran-
rant transcriptional repressors due to inappropriate recruitment scriptional repressor functions in leukemia, little is known about
of histone deacetylases (HDACs) (Kra¨mer et al., 2001; Melnick genetic causes for aberrant repression in epithelial forms of
and Licht, 2002). The recruitment of histone acetyltransferases cancer.
and HDACs is considered to be a key element in the dynamic Colonic cancer is frequently associated with aberrant signal-
regulation of many genes regulating cellular proliferation and ing through the Wnt pathway due to loss of both functional
differentiation during normal development and carcinogenesis copies of the tumor suppressor adenomatosis polyposis coli
(Berger, 2002; Glass and Rosenfeld, 2000; Jenuwein and Allis, (APC) and/or mutations in the -catenin gene, although addi-
2001; Strahl and Allis, 2000). Mammalian histone deacetylases tional mutations are required for cancer development (Fodde,
can be divided into three subclasses (Verdin et al., 2003). HDACs 2003; Giles et al., 2003; Kinzler and Vogelstein, 1996). APC is
1, 2, 3, and 8, which are homologs of the yeast RPD3 protein, a key component of the -catenin destruction complex that is
constitute class I. HDACs related to the yeast Hda1 protein form required for basal turnover and Wnt-induced stabilization of
class II, and mammalian homologs of the yeast Sir2 protein -catenin. Wnt signaling prevents GSK-3-dependent phos-
constitute the third class. HDACs are usually subunits of multi- phorylation and subsequent APC-dependent degradation of
-catenin. Loss of functional APC leads to reduced turnoverprotein complexes, for example the transcriptional corepressors
S I G N I F I C A N C E
HDAC inhibitors are considered promising novel anticancer drugs, and prove useful in preclinical and first clinical trials. Nevertheless,
little is known about whether aberrant transcriptional repression plays a role in the development of solid tumors, or which might
be the critical components of the transcriptional repression machinery. Knowledge of mechanisms of faulty HDAC-dependent
transcriptional repression acquired during the development of solid tumors would allow screening for such forms of cancer that can
be expected to respond to therapy with HDAC inhibitors. Also, specific isoenzymes in the family of more than ten HDACs may be
identified which appear as particular relevant targets for the development of isoenzyme-specific HDAC inhibitors.
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and accumulation of -catenin protein. Although -catenin in-
fluences a number of cellular processes, the primary function
of accumulated -catenin in intestinal cancer development
appears to be mediated by interaction with the Tcf-4/Lef1 tran-
scription factors (Behrens et al., 1996; Molenaar et al., 1996;
Morin, 1999). Known target genes are Cyclin D1 (Shtutman et
al., 1999; Tetsu and McCormick, 1999), c-Myc (He et al., 1998),
and PPAR (He et al., 1999), among several other target genes
of the Wnt pathway (http://www.stanford.edu/rnusse/pathways/
targets.html). Only for some of these genes has a link to the
transformed phenotype of cancer cells been established.
We now show a link between tumor suppression in colonic
cancer and aberrant transcriptional repression. Loss of func-
tional APC leads by a Myc-dependent mechanism to overex-
pression of an apparently rate-limiting component of the tran-
scriptional repression machinery, HDAC2. High expression of
HDAC2 is required and sufficient to maintain a transformed
cellular phenotype with respect to the lack of apoptosis in cul-
tured colonic cancer cells. Increased expression of HDAC2 in
APC mutant mice and severe reduction of adenoma formation
upon interference with HDAC2 indicate that HDAC2 is a critical
target of APC in vivo that is accessible to pharmacological
interventions.
Results
Wild-type APC represses HDAC2 expression
APC-deficient HT-29 colonic cancer cells fail to grow in the
presence of HDAC inhibitors (Go¨ttlicher et al., 2001). Therefore,
we tested whether APC status affects HDAC expression by
using HT-29 cells in which wild-type APC is expressed from
a Zn2-inducible transgene (Morin et al., 1996). Expression of
HDAC2 was significantly reduced, both at the mRNA (to 42%
at 48 hr) and protein (to 21% from 48 hr onward) levels after
induction of wild-type APC (Figures 1A and 1B). Downregulation
of PPAR mRNA (to 21% at 48 hr) served as control for APC
reconstitution. Expression of-Gal instead of APC proved spec-
Figure 1. HDAC2 is regulated by the APC/-catenin pathwayificity (He et al., 1999). Expression of two other class I HDACs,
A: HDAC2 mRNA levels and expression of PPAR and GAPDH for controlsHDAC1 and 3, was not changed within the range of 20% of
were determined by Northern blot hybridization in HT-29 cells expressing
signal intensity, indicating a selective effect on HDAC2 (Figure APC or -Gal from a Zn2-inducible transgene.
1B). As APC promotes -catenin degradation, we further tested B: Downregulation of HDAC2 protein upon restoration of wild-type APC was
confirmed by Western blot analysis with HDACs 1 and 3 for comparison.whether -catenin/Tcf-4/Lef1 dependent transcription is in-
C: Induction of HDAC2 expression and the expected accumulation ofvolved in the regulation of HDAC2 expression. GSK-3 phos-
-catenin were determined upon GSK-3 inhibition by LiCl.phorylates -catenin and consequently promotes -catenin D: The role of Tcf-4/Lef1 for high level HDAC2 expression in APC-deficient
degradation. To test its role in HDAC2 expression, we inhibited HT-29 cells was tested by expressing a dominant-negatively acting mutant
form of Tcf-4 at efficiencies of transient transfections greater than 50% asGSK-3 by lithium (15 mM) to allow for a 6.9-fold accumulation
determined by parallel transfection of a GFP expression vector pCMV-GFP.of -catenin protein in HEK293T cells containing wild-type APC
Untransfected cells and transfection of the empty expression vector served(Phiel and Klein, 2001; Stambolic et al., 1996). HDAC2 mRNA
as controls.
(data not shown) and protein expression was elevated by 4.1- E: Occupancy of the binding site for c-Myc in the HDAC2 promoter was
fold upon -catenin accumulation (Figure 1C). Lithium also in- determined by chromatin immunoprecipitation. Wild-type APC or -Gal
were induced by Zn2 treatment, and presence of the DNA fragment cov-duced HDAC2 levels in Zn2-treated HT29-APC cells, although
ering the Myc binding site was detected by PCR in input cell lysates (5%)time courses are complicated due to combined effects of APC
or anti-c-Myc immune precipitates. For controls, precipitates were prepared
induction on apoptosis and GSK-3 inhibition (data not shown). in the absence of antibody, or specific anti-c-Myc precipitates were sub-
Furthermore, transfection of a dominant-negative mutant of jected to PCR amplification for a nonrelated fragment of the HDAC2 pro-
moter (Myc/nr).Tcf-4 in APC-deficient HT-29 cells led to a reduction of HDAC2
F: The effect of siRNA directed against c-Myc was analyzed by WesternmRNA (data not shown) and protein levels (to less than 50%,
blot analysis. Similar results were obtained in 2 or 3 additional experimentsFigure 1D), while -catenin levels were unchanged. These data
(B), respectively.
indicate that HDAC2 expression depends on -catenin and
Tcf-4/Lef1, and is increased in cells lacking functional APC. The
delay of HDAC2 expression upon LiCl exposure suggested the
need for synthesis of intermediary factors such as c-Myc or
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Figure 2. HDAC2 is overexpressed in human colo-
rectal carcinomas
Colonic tumor samples and patient-matched
normal tissues were compared for HDAC2 ex-
pression and -catenin levels by immunohisto-
chemistry in the form of 46 spots of tumor and
control tissue, respectively, on a multiple tissue
array and 11 classical histological sections.
A: Representative double-immunofluorescent
stainings of a tissue array sample and a classical
tumor sample with normal tissue next to it are
shown. Assigned scores are indicated in each
frame.
B: The tables summarize scoring results from 57
tumor samples. Distribution of samples over the
score classes as well as the average score and
statistic evaluation by Student’s t test are pre-
sented in the upper table. The lower table sum-
marizes the differences between tumor and nor-
mal tissue. The number of samples is shown in
which all combinations of differences in HDAC2
or -catenin expression were found. -Cat,
-catenin; no, normal tissue; tu, tumor.
PPAR. A role of c-Myc is likely, since the promoter region that (82%), and more than 1 score point difference between normal
and tumor tissue was found on average (Figure 2B). In the vastharbors a binding site for c-Myc at 621 to 616 bp upstream of
the HDAC2 start codon is occupied with c-Myc in HT-29 cells majority of samples, HDAC2 and -catenin were regulated
in the same way, suggesting that they are, in most cases,as shown by chromatin immunoprecipitation (ChIP) assays. Ex-
pression of wild-type APC by Zn2 induction virtually abolished related events in the development of colonic cancer (Figure 2B).
Only 5 samples did not show elevated HDAC2 levels despitepromoter occupancy with c-Myc (Figure 1E). The functional
significance of Myc was tested by siRNA transfection. siRNA immunologically detectable increased levels of -catenin, which
could be due to additional defects in the -catenin/Tcf pathway.efficiently knocked down Myc protein expression by 49% and
HDAC2 expression by 67%, whereas, as expected, -catenin Elevated HDAC2 expression without apparent increases in
-catenin levels was observed in 11 samples. This may be duelevels were not affected (Figure 1F). Downregulation of HDAC2
appears to be even more pronounced than that of c-Myc, which to the limited quantitative power of immunohistochemistry,
or it may indicate that HDAC2 expression and accumulationmay be due to the timing of the experiment.
of -catenin are not always associated. Other mechanisms of
HDAC2 upregulation, such as Myc amplification may exist inElevated HDAC2 levels in human colonic cancer
addition to APC/-catenin signaling. The separate analysis ofWe compared 57 samples of mostly moderately differentiated
TNM-T3 or -T4 tumors versus patient-matched normal tissues 6 mucinous type, 11 well differentiated, or 2 poorly differentiated
samples, respectively, did not yield any significant differencewith respect to alterations in HDAC2 and-catenin levels (Figure
2A). Elevated HDAC2 expression was observed in 47 samples compared to the analysis of all samples. Neither did the analysis
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Figure 3. HDAC2 is required for survival of HT-29 cells
HDAC2 was knocked down in HT-29 cells by transfection of a double-stranded siRNA.
A: HDAC2 protein levels were determined at indicated times after siRNA addition by Western blot analysis. HDAC1 and 3 were determined to assess
specificity of downmodulation, and Luc siRNA as well as nontransfected cells served as control.
B: Downmodulation at the mRNA level was confirmed 48 hr after siRNA addition by semiquantitative RT-PCR reactions of polyA-RNA, with two housekeeping
genes (hypoxanthine phosphoribosyltransferase [HPRT] and actin) serving as controls.
C: Cell numbers were determined upon HDAC2 downmodulation by counting attached cells per culture at indicated times after siRNA transfection. Values
are means  range of duplicate samples.
D: Control and HDAC2-depleted cells were analyzed 48 hr after transfection for DNA content for determination of cell cycle distribution and assignment
of a presumably apoptotic fraction of cells with sub-G1 amounts of DNA.
E: Signs for induction of apoptosis were obtained at indicated times after siRNA addition by collecting attached and floating cells. The relative fraction of
cells with fragmented or condensed nuclei (left panel) was assessed microscopically. Quantitative apoptotic indices (right panel) scored cytoplasmic
histone-associated DNA fragments generated during the apoptotic process. A–D show one representative example out of three sets of experiments with
similar results. Values in E are means  range from duplicate experiments.
of the 11 classical tumor sections with tumor and normal tissue control cultures displayed no difference in growth kinetics (Fig-
ure 3C). The significant reduction of cell numbers does notpresent on the same slide differ significantly from the evaluation
of all samples together. As a general conclusion from the immu- appear to be due to lack of proliferation, since the distribution
of cells over G1 and S/G2 phases of the cell cycle was notnohistochemical analysis, elevated HDAC2 levels are found at
an even higher frequency in colonic cancer samples than ele- altered (Figure 3D). A substantial fraction of cells with sub-G1
amounts of DNA rather suggests that knockdown of HDAC2 orvated -catenin levels in the present or published studies (Hugh
et al., 1999; Valizadeh et al., 1997). VPA treatment of HT-29 cells might induce apoptosis. Induction
of apoptosis upon HDAC2 knockdown was confirmed by count-
ing cells with fragmented and condensed nuclear DNA andHDAC2 is required for HT-29 cell survival
Expression of wild-type APC in HT-29 cells in culture had been a quantitative assay for cytoplasmic histone-associated DNA
fragments (Figure 3E). In summary, the knockdown data suggestshown to reduce cell numbers and to induce apoptosis (Morin
et al., 1996, and our unpublished data). To test whether lack of that HDAC2 is required for HT-29 cell survival, and that down-
modulation to a level comparable to that in APC-proficient cellsHDAC2 alone would suffice to impair HT-29 cell growth, we
knocked down HDAC2 protein levels to less than 30% by trans- suffices to induce apoptosis. Similar experiments addressing
HDAC3 achieved reduction of protein levels by only 50%, with-fection of siRNA directed against HDAC2 (Figure 3A). Downmo-
dulation of HDAC2 occurred on the mRNA level, indicating a out detectable effects on cell survival (data not shown).
The critical role of HDAC2 in the prevention of apoptosisspecific activity of the siRNA (Figure 3B). Cell cultures trans-
fected with HDAC2 siRNA showed significantly reduced growth, was confirmed by a second independent approach, which
should also clarify whether ectopic expression of HDAC2 alonewith cell counts reduced by more than 50% after 3 days, while
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late the need for additional proapoptotic signals upon reconsti-
tution of wild-type APC. Also, additional antiapoptotic signals
in addition to high-level HDAC2 expression in APC-deficient
cells do not need to be postulated from the present experiments,
since overexpression of HDAC2 alone suffices to substantially
protect from initiation of apoptosis upon reconstitution of wild-
type APC (Figures 1 and 3). Nevertheless, other mechanisms
to control apoptosis may exist downstream of APC that are not
apparent in the present experiments but may exist in other cell
types or under other experimental conditions.
The APC/-catenin/HDAC2 pathway in mice
To test whether HDAC2 is a relevant target of the APC/-catenin
pathway in vivo, we analyzed HDAC2 in APCmin and Apc1638N
mice (Fodde et al., 1994; Shoemaker et al., 1997; Su et al.,
1992). HDAC2 protein levels are elevated in intestinal polyps of
APCmin mice compared to normal tissue (Figure 5A). In wild-Figure 4. Ectopic expression of HDAC2 antagonizes APC-induced apoptosis
type mice, HDAC2 is preferentially detectable in the lower zoneHT29-APC cultures were transfected at low efficiency with an empty expres-
of regenerative proliferation (Figure 5A), as described previouslysion vector or a vector for HDAC2 to maintain high levels of HDAC2. A GFP
expression vector was cotransfected to allow tracing the small fraction of for nuclear -catenin accumulation and expression of Tcf-4
efficiently transfected cells by flow cytometry. Wild-type APC was induced target genes (van de Wetering et al., 2002). Also, in apparently
by addition of ZnCl2 in half of the cultures to decrease endogenous HDAC2 normal tissue, HDAC2 levels were moderately higher in APCmin
levels (and to induce apoptosis). At the indicated time points after addition
mice. Moreover, protein levels did not decrease toward theof Zn2, attached cells were harvested for detection of GFP-positive cells
upper zone of the epithelium (Figure 5A). Differences in HDACby FACS. Percentages of GFP-positive cells in cultures without Zn2 were set
to 1 at each time point and the relative increase in the percentage of GFP- protein expression were confirmed by Western blot analysis of
positive cells in Zn2 treated cultures was calculated as an indicator of extracts prepared from tumor tissues or scrapings of intestinal
preferential loss by apoptosis of those cells that were not transfected. Values mucosa (Figure 5B). HDAC2 expression is higher in normal tis-are means  S.D. from two independent experiments with duplicate deter-
sues and more pronounced in tumors from APC mutant miceminations each. Absolute percentages of GFP-positive cells were in the
range of 0.5–4%, depending on time point of analysis. compared to normal tissues of wild-type mice. HDAC3 expres-
sion did not differ between wild-type and APC mutant mice
(Figure 5B and histology not shown), whereas HDAC7 levels
rather appeared to be lower in tumors. In contrast to adenomas
suffices to prevent apoptosis. HDAC2 was expressed from a expressing only mutant APC due to somatic inactivation of
transiently transfected vector, while endogenous HDAC2 was the second allele, normal intestinal epithelium of heterozygous
downregulated by Zn2-induced expression of wild-type APC. APCmin mice usually expresses wild-type APC protein and APCmin
Transfected cells were identified by flow cytometry upon coex- protein at similar levels (Shoemaker et al., 1997). Thus, aberrant
pression of green fluorescent protein (GFP). If HDAC2 would patterns of HDAC2 expression in apparently normal mucosa of
not affect induction of apoptosis, normal and green fluorescent APCmin mice suggest haploinsufficiency of APC with respect to
cells should be eliminated by apoptosis at the same rate, downregulation of HDAC2 toward the upper zone of the intesti-
and their ratio should not change. The experiment, however, nal epithelium.
showed enrichment of fluorescent cells (Figure 4). Reduction of To assess the role of HDAC2 in adenoma formation, we
untransfected HT29-APC cell numbers to about 40% by 72 hr treated APCmin mice with valproic acid (VPA) to inhibit class I
exposure to Zn2 led to a more than 2-fold enrichment of HDACs and to induce degradation of HDAC2 (Go¨ttlicher et al.,
HDAC2-transfected cells. This indicates that almost all effi- 2001; Kra¨mer et al., 2003; Phiel et al., 2001). Increased bulk
ciently transfected cells had to be protected from apoptosis. histone H3 acetylation indicated efficiency of HDAC inhibition,
Control transfection of the empty vector together with GFP did and reduction of HDAC2 levels but not of HDAC3 was confirmed
not enrich transfected cells. These data indicate a prominent by immunohistochemistry (Figure 5C and data not shown). VPA
role of overexpressed HDAC2 in protection of APC-proficient significantly reduced number and average size of adenomas
cells from apoptosis. They suggest that elevated HDAC2 ex- in entire intestinal tracts (Figures 5D and 5E). Particularly, only
pression is a key mechanism in prevention of apoptosis in APC- 10% of the large tumors (diameter1 mm) were found after VPA
deficient cells. treatment. In summary, the analysis of APCmin mice supports
The possibility cannot be excluded that APC affects apopto- the conclusion that loss of functional APC also leads to in-
sis also by additional mechanisms. Those, however, appear creased HDAC2 expression in vivo, and that aberrant HDAC
unlikely to be able to overcome the control mediated by HDAC2 activity is required for development of APCmin dependent intesti-
in HT-29 cells. Reconstitution of wild-type APC or transfection nal adenomas.
of siRNA in APC-deficient cells reduces HDAC2 protein levels
to a similar extent. In the latter case, HDAC2 depletion suffices Discussion
to induce apoptosis despite the lack of functional APC. If it is
assumed that reduction of HDAC2 expression upon reconstitu- Elevated expression of HDAC2 upon increased signaling
through the APC/-catenin/c-Myc pathway establishes an ex-tion of wild-type APC expression likewise provides a functionally
equivalent proapoptotic stimulus, one would not have to postu- ample for aberrant function of the HDAC-dependent transcrip-
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Figure 5. Intestinal HDAC2 expression and ade-
noma development in VPA-treated APCmin mice
HDAC2 expression and adenoma formation
were analyzed by histological and macroscopic
evaluation of guts from heterozygous APC mu-
tant mice and litter-matched wild-type animals.
A: Immunohistochemical detection of HDAC2
in the ileum is shown for 12-week-old wild-
type mice (normal mucosa) and litter-matched
APCmin mice. Pictures of macroscopically appar-
ently normal mucosa and a representative polyp
are taken from the same section. No staining was
observed in control experiments without primary
antibody. Scale bars indicate 100 m.
B: Amounts of HDAC proteins were determined
by Western blot analysis in equal amounts of solu-
ble protein extracts obtained from scrapings of
intestinal mucosa (N) or tumor tissues (T) of wild-
type (wt) or Apc1638N (mut APC) mice (Janssen et
al., 2002).
C: The degrees of histone acetylation and
HDAC2 expression were determined in the ileum
of APCmin mice that had been injected (i.p.) with
PBS or VPA for 4 weeks. Adenomas are marked
by dashed lines.
D: Adenoma formation on entire intestinal tract
was quantitatively evaluated in APCmin mice that
had been injected (i.p.) with PBS (P, n  4) or
VPA (V, n  5) for 4 weeks. Large polyps were
those with a diameter  1 mm. Values are
means  S.D. P values were calculated by Stu-
dent’s t test.
E: Polyps appear in dark blue circular staining
in representative ileum segments from experi-
ments in D.
tional repression machinery in nonhematopoietic cancer cells. lished data). Sulindac is thought to interfere with DNA binding
of PPAR (He et al., 1999) and reduces HDAC2 expression byElevated HDAC2 expression prevents apoptosis in cultured
cells, and interference with HDACs reduces tumor formation in 50% in HCT116, but only marginally in HT-29 cells (P.Z. and
M.G., unpublished data). Human xenograft growth in mice sub-APCmin mice.
APC regulates HDAC2 most likely at the transcriptional level, stantially depends on PPAR, whereas adenoma development
in APCmin mice does not (Barak et al., 2002; Park et al., 2001).because APC does not affect the initial rate of HDAC2 mRNA
degradation after inhibition of de novo synthesis by actinomycin Thus, different components of the Wnt pathway contribute to
HDAC2 expression and Tcfs, c-Myc, occasionally PPAR, andD (data not shown). Interference by a dominant-negative mutant
of Tcf suggests that either Tcf-4/Lef1 or a Tcf-4/Lef1-depen- probably Ras are prominent factors.
Induction of HDAC2 upon loss of APC represents a noveldently induced protein such as c-Myc or PPAR induces HDAC2
transcription (He et al., 1998, 1999). Sequence analysis and mechanism for aberrant function of the HDAC-dependent tran-
scriptional repression machinery upon genetic defects that pro-EMSA analyses of the HDAC2 promoter (Zeng et al., 1998)
suggested that this could be c-Myc. Experimental evidence for mote the development of cancer. Such links are sparse in carci-
nomas in contrast to numerous examples in leukemia (Kra¨mera functional role of c-Myc in expression of HDAC2 is provided
here by showing reduction of HDAC2 expression upon knock- et al., 2001; Melnick and Licht, 2002). The polycomb group
protein enhancer of zeste 2 apparently promotes prostate can-down of c-Myc. c-Myc expression is also elevated by protein
stabilization upon K-Ras activation (Sears et al., 1999). There- cer development by HDAC-dependent transcriptional repres-
sion (Varambally et al., 2002). The BRCA tumor suppressorsfore, activation of this protooncogene with critical roles in co-
lonic cancer development is likely to increase HDAC2 expres- function as both transcriptional activators and repressors. It is,
however, not clear if and how this is related to carcinogenesission. PPAR appears to contribute to HDAC2 regulation in some
cell types. Disruption of one PPAR allele in embryonic stem (Monteiro, 2000; Scully, 2001). A link between tumor develop-
ment in APC-deficient mice and regulation of gene expressioncells reduces HDAC2 expression by 50% (P.Z. and M.G., unpub-
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and chromatin structure had been described in DNA methyl- carcinoma, because HDAC2 expression is elevated in most of
the human colonic cancer samples. Furthermore, 4 out of 8transferase (DNMT)-deficient mice. Genetic inactivation of one
of the DNMT alleles and chemical inhibition by 5-aza-deoxycyti- human colonic cancer cell lines showed a strong reduction of
cellular biomass upon VPA treatment, while the remaining onesdine severely reduced the numbers of polyps formed (Laird et
al., 1995). The concepts of DNA methyltransferase and histone showed a moderate decrease (E.M., unpublished data). Since
progression of cancer requires many cellular features, it is likelyacetylation might address related aspects of the same biological
process in colon tumorigenesis, in which histone deacetylation that combinations of drugs targeting different pathways will
be appropriate with HDAC2 inhibitors supporting induction ofmight provide the most dynamic and transient mode of down-
regulation of critical target genes. At later stages, this downregu- apoptosis in cancer cells.
lation may become more stably established by DNA methylation.
Experimental proceduresThe recruitment of individual HDACs and HDAC-containing
complexes to critical target genes by transcription factors might
Cell culture and transfections
provide a level of specificity that is not apparent from alterations Cell culture and transgene induction by 100 M Zn2 have been described
in bulk DNA methylation rates. The present data and preliminary (He et al., 1999; Kra¨mer et al., 2003). Plasmid and siRNA were transfected
gene expression profiles obtained after knockdown of HDAC2 with Lipofectamine 2000 and Oligofectamine (Invitrogen, Carlsbad, Califor-
nia) according to the manufacturer’s instructions. Briefly, the HDAC2 expres-(data not shown) indicate that critical processes during carcino-
sion vector pCMV-mRPD3-2.1 (Yang et al., 1996) was cotransfected withgenesis exist in which levels of HDAC2 are limiting. Other HDACs
pCMV-GFP at a ratio of 5:1. Twelve hr after transfection, cells were replatedobviously serve limiting roles in other biological processes, such
into two samples each before ZnCl2 was added to one of them. Attachedas control of proliferation during embryogenesis (HDAC1, Lag- cells were harvested 24 to 72 hr later, and the fraction of GFP-positive
ger et al., 2002) or stress response of the heart (HDAC9, Zhang cells was determined by flow cytometry. pcDNA/Myc-	N-hTcf4 (dominant-
et al., 2002). negative mutant of Tcf-4, Korinek et al., 1997) or empty pcDNA3.1() was
transiently transfected into HT-29 cells, and parallel cultures were processedSince the lack of functional APC alone is not sufficient to
42 hr later for Western and Northern blot analysis. In this experiment, 3 
trigger all the processes critical for tumor development (Giles
105 cells were seeded per well of 6-well plate one day before transfection.et al., 2003), it is also unlikely that elevated HDAC2 expression
Transfections were performed in the absence of FCS and antibiotics foris sufficient. However, HDAC2 appears to be required for some
4 hr, using 3 g DNA and 8 l Lipofectamine 2000 per well. Then FCS was
critical steps, since interference with HDAC2 reduces tumor added to 10% and cells were cultured until analysis. Transfection efficiencies
formation in APCmin mice and elevated HDAC2 levels are found were monitored by parallel transfection of the GFP expression vector pCMV-
GFP. HT-29 cells were transfected in daily intervals with appropriate siRNAsat high frequency in human colon cancer samples. HDAC2,
for 48 hr (c-Myc) or indicated time periods. siRNAs were 5-AAGCCUCAUAthough not necessarily induced by loss of APC, may even be
GAAUCCGCAUG-3 (HDAC2), 5-AACGUUAGCUUCACCAACAGG-3 (c-Myc)critical in other carcinomas, since HDAC2 levels are elevated
(van de Wetering et al., 2002), and 5-AACGUACGCGGAAUACUUCGA-3 (Luc)in many tumor cell lines compared to normal tissue more pro-
(Elbashir et al., 2001).
nouncedly than other HDACs (Yang et al., 1997). Furthermore,
examples of gastric, breast, and lung carcinoma on a multiple Western and Northern blot
tissue array show increased expression of HDAC2 protein in Antibodies for Western blot analysis of whole cell extracts were (Santa
Cruz Biotechnology, California): HDAC1, sc-6298; HDAC2, sc-9959; HDAC3,tumors compared to the corresponding normal tissues included
sc-8138; HDAC7, sc-11489; -catenin, sc-1496; actin, sc-1616; c-Myc,on the same tissue array (data not shown). While prevention of
sc-40. Actin was determined in all Western blots to ensure equal loadingapoptosis appears to be the prominent effect of elevated
of lanes. Probes for Northern hybridizations (5 g poly[A] RNA per lane)HDAC2 expression in cell lines derived from colon cancer (HT-
corresponded to nucleotides 1336–1647 of mHDAC2 coding region and
29) or melanoma (O. Kra¨mer and T. Heinzel, personal communi- complete coding sequences of mPPAR and rGAPDH. Films were quantita-
cation), it is not clear whether reduced adenoma formation in tively evaluated using the Aida software (Berthold, Germany).
APCmin mice upon HDAC inhibition is also due to apoptosis.
RT-PCRApoptosis rates were below detection limits in wild-type and
First-strand cDNA was generated using the RNeasy and Oligotex mRNAmutant mice, possibly due to rapid shedding of apoptotic cells
mini kits (Qiagen, Hilden, Germany) and Superscript II Reverse Transcriptasefrom the epithelium (data not shown).
(Invitrogen, Karlsruhe, Germany). Five l of first-strand cDNA preparations
The link between APC and HDAC2, although depending on were used in PCR reactions with 30, 32, and 34 (HDAC2) or 25 and 27
additional factors such as c-Myc, provides a reason for the cycles (HPRT and Actin) to ensure that amplification was in the linear
susceptibility of carcinomas of epithelial origin to treatment with range. Primers were: HDAC2, 5-GCTATTCCAGAAGATGCTGTTC-3 and
HDAC inhibitors. Furthermore, it indicates that HDAC2 might 5-GTTGCTGAGCTGTTCTGATTTG-3; HPRT, 5-CCAAAGATGGTCAAG
GTC-3 and 5-CTGCTGACAAAGATTCACTGG-3; Actin, 5-TCACCCACACbe a particularly suitable target for selective inhibition of HDACs.
TGTGCCCAT-3 and 5-CTCTTGCTCGAAGTCCAGGG-3.VPA serves as a model drug. It has been used in therapy of
epilepsy for decades and induction of differentiation in cancer
Chromatin immunoprecipitation
cells had been described (Blaheta and Cinatl, 2002). Only re- HT29-APC and HT29-GAL cells were treated with 100 M ZnCl2 for 18 hr
cently has it become apparent that VPA preferentially inhibits as indicated. Cells were fixed in 1% formaldehyde and harvested for prepar-
the catalytic activity of class I HDACs (Go¨ttlicher et al., 2001; ing nuclei in lysis buffer (50 mM Hepes [pH 8], 1 mM EDTA, 0.5 mM EGTA,
150 mM NaCl, 10% glycerol, 0.5% NP40, 0.2% Triton X-100, proteasePhiel et al., 2001) and, in addition, induces proteasomal degra-
inhibitors cocktail [Roche, Mannheim, Germany]). Washed nuclei were lyseddation of HDAC2 (Kra¨mer et al., 2003). Substantial but incom-
in RIPA buffer (10 mM Tris-HCl [pH 8], 1 mM EDTA, 0.5 mM EGTA, 150 mMplete effects of VPA on polyp formation in APCmin mice may be
NaCl, 0.1% sodium deoxycholate, 0.1% SDS, 1% Triton X-100, proteasedue to the short half-life of VPA in rodents, which prevents
inhibitors cocktail). Chromatin was broken into 500–800 bp DNA fragments
maintenance of efficient serum levels over the day (Go¨ttlicher by sonication. Following preclear by incubating 1 ml lysates with 25 l of
et al., 2001). VPA treatment is likely to be successful not only protein A sepharose CL-4B and 5 g sheared salmon sperm DNA for 2 hr,
immunoprecipitation was performed with 5 g of a specific anti-c-Myc anti-during adenoma formation, but also after development of the
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body (sc-764, Santa Cruz Biotechnology, California) overnight at 4C. Protein APC cells, pcDNA/Myc-	N-hTcf4, pCMV-mRPD3-2.1, and mPPAR cDNA,
A Sepharose (25 l) and 10 g/ml salmon sperm DNA were added for respectively). The study was supported by the Forschungszentrum Karlsruhe
another 1 hr. Precipitates were washed sequentially in RIPA buffer, RIPA (fellowship to P.Z.) and the AICR, St. Andrews, UK (grant to M.G.). E.M. and
buffer with 10 g/ml salmon sperm DNA, RIPA buffer with 10 g/ml salmon J.M. are employees of G2M Cancer Drugs AG, which has a financial interest
sperm DNA and 500 mM NaCl, and RIPA. Precipitate-associated DNA was in inhibitors of histone deacetylases.
eluted with 50 mM Tris-HCl (pH 8), 1 mM EDTA, 100 mM NaCl, 0.5% SDS,
100 g/ml proteinase K for 3 hr at 55C and then overnight at 65C, and
purified with a QIAquick Spin Kit (Qiagen, Hilden, Germany). DNA was used
for PCR detection with the following primers: c-Myc biding site flanking Received: December 12, 2003
primers: forward (731) CGA CAA ACG AGA AAA CTA GGC; reverse (360) Revised: February 26, 2004
TTA GGG TGA ACA ACC TGC GCA; control primers for a nonrelated region Accepted: March 25, 2004
of the HDAC2 promoter: forward (1788) CGT ACA TGG CAT GGA GAA Published: May 17, 2004
CAG; reverse (1635) CTT GGA AGA TTC TGA GAA CAG. Numbers indicate
upstream positions relative to the start codon of HDAC2. References
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